1-5 of 5
gilteritinib
Close
Sort by
Journal Articles

ETV6-FLT3– positive myeloid/lymphoid neoplasm with eosinophilia presenting in an infant: an entity distinct from JMML

Clinical Trials & Observations
Barbara Spitzer, Filemon S. Dela Cruz, Glorymar D. Ibanez Sanchez, Yanming Zhang, Wenbin Xiao, Ryma Benayed, Alina Markova, M. Irene Rodriguez-Sanchez, Nancy Bouvier, Mikhail Roshal, Andrew L. Kung, Neerav Shukla
Journal: Blood Advances
Blood Adv (2021) 5 (7): 1899–1902.
https://doi.org/10.1182/bloodadvances.2020003699
Published: 2021
Journal Articles

Gilteritinib: potent targeting of FLT3 mutations in AML

Clinical Trials & Observations
Mark Levis, Alexander E. Perl
Journal: Blood Advances
Blood Adv (2020) 4 (6): 1178–1191.
https://doi.org/10.1182/bloodadvances.2019000174
Published: 2020
Journal Articles

Gilteritinib is a clinically active FLT3 inhibitor with broad activity against FLT3 kinase domain mutations

Clinical Trials & Observations
Theodore C. Tarver, Jason E. Hill, Leena Rahmat, Alexander E. Perl, Erkut Bahceci, Kenichi Mori, Catherine C. Smith
Journal: Blood Advances
Blood Adv (2020) 4 (3): 514–524.
https://doi.org/10.1182/bloodadvances.2019000919
Published: 2020
Includes: Supplemental data
Journal Articles

Erythroid differentiation of myeloblast induced by gilteritinib in relapsed FLT3 - ITD –positive acute myeloid leukemia

Hyun Don Yun, Sunita Nathan, Melissa Larson, Mohammad J. Hussain, Deborah A. Katz, Ankur Varma, Ira Miller, Celalettin Ustun
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3709–3712.
https://doi.org/10.1182/bloodadvances.2019000775
Published: 2019
Journal Articles

Gilteritinib induces differentiation in relapsed and refractory FLT3 -mutated acute myeloid leukemia

Clinical Trials & Observations
Christine M. McMahon, Jonathan Canaani, Bryan Rea, Rachel L. Sargent, Julianne N. Qualtieri, Christopher D. Watt, Jennifer J. D. Morrissette, Martin Carroll, Alexander E. Perl
Journal: Blood Advances
Blood Adv (2019) 3 (10): 1581–1585.
https://doi.org/10.1182/bloodadvances.2018029496
Published: 2019
Includes: Supplemental data